ราคาของ Formosa Pharmaceuticals, Inc. (6838) คืออะไร

ราคาของ Formosa Pharmaceuticals, Inc. (6838) คือ $0.79338575

หมวกตลาดของ Formosa Pharmaceuticals, Inc. คืออะไร (6838)

ฝาครอบตลาดของ Formosa Pharmaceuticals, Inc. (6838) คือ $119.78M

ประวัติราคาของ Formosa Pharmaceuticals, Inc. (6838)

Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei City, Taiwan, is actively engaged in both late-preclinical and early clinical development stages. Its core focus lies in pioneering therapeutic candidates across ophthalmology, oncology, and anti-infective domains. Among its key investigational assets is APP13007, an ophthalmic nanosuspension, currently progressing through Phase III trials for managing post-surgical discomfort and inflammation of the eye. The company's portfolio also encompasses TSY-0110, designed as an antibody-drug conjugate, and TSY-0210, an antibiotic targeting resilient drug-resistant infections. Further compounds under development include APP13002, a topical antibiotic intended for ocular infections like blepharitis, and MPT0E028, a novel pan-histone deacetylase inhibitor being explored for solid malignancies such as hepatomas and colorectal cancer, in addition to lung fibrosis. Additionally, Formosa Pharmaceuticals maintains a collaborative partnership with Eyenovia, Inc., dedicated to advancing innovative ophthalmic treatments. Established in 2010, the company is headquartered in Taiwan's capital.

ปี	ประสิทธิภาพ
2026 (TTM)	1.64%
2025	-27.82%
2024	-24.76%
2023	-6.74%
2022	43.68%
2021	0.00%

ปี

ประสิทธิภาพ

2026 (TTM)

1.64%

2025

-27.82%

2024

-24.76%

2023

-6.74%

2022

43.68%

2021

0.00%

บริษัท	ราคาหุ้น	การเปลี่ยนแปลง 1ปี%	ประเทศ
Vertex Pharmaceuticals Incorporated VRTX.US	$547.71	38.62%	US
Argenx SE ARGX.US	$1.04K	58.06%	NL
Moderna, Inc. MRNA.US	$145.75	437.43%	US
CSL Limited CSL.AX	$119.69	-14.89%	AU
Lonza Group AG LONN.SW	$770.19	8.98%	CH

บริษัท

ราคาหุ้น

การเปลี่ยนแปลง 1ปี%

ประเทศ